Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated, Viral Vector, mRNA, Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases {Hepatitis, Influenza, Human Papillomavirus, Measles/Mumps/Rubella, Rotavirus, Herpes Zoster}, and Bacterial Diseases {Meningococcal Disease, Pneumococcal Disease, Diphtheria/Tetanus/Pertussis}), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 7.8% from 2024-2032

Unit

Value (USD Billion)

Segmentation

By Type

• Recombinant/Conjugate/Subunit
• Inactivated
• Live Attenuated
• Viral Vector
• mRNA
• Toxoid
• Others

By Route of Administration

• Parenteral
• Oral

By Disease Indication

• Viral Diseases
• Hepatitis
• Influenza
• Human Papillomavirus
• Measles/Mumps/Rubella
• Rotavirus
• Herpes Zoster
• Others
• Bacterial Diseases
• Meningococcal Disease
• Pneumococcal Disease
• Diphtheria/Tetanus/Pertussis
• Others

By Age Group

• Pediatric
• Adults

By Distribution Channel

• Hospital & Retail Pharmacies
• Government Suppliers
• Others

By Region

• North America (By Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, and Country)
• U.S. (By Type)
• Canada (By Type)
• Europe (By Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, and Country/Sub-region)
• U.K. (By Type)
• Germany (By Type)
• France (By Type)
• Italy (By Type)
• Spain (By Type)
• Scandinavia (By Type)
• Rest of Europe (By Type)
• Asia Pacific (By Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, and Country/Sub-region)
• China (By Type)
• Japan (By Type)
• India (By Type)
• Australia (By Type)
• Southeast Asia (By Type)
• Rest of Asia Pacific (By Type)
• Latin America (By Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, and Country/Sub-region)
• Brazil (By Type)
• Mexico (By Type)
• Rest of Latin America (By Type)
• Middle East & Africa (By Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, and Country/Sub-region)
• GCC (By Type)
• South Africa (By Type)
• Rest of the Middle East & Africa (By Type)